Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07121894 · ClinicalTrials.gov registry record · NA
Ketogenic Intervention for Bipolar Depression
A NA study of Bipolar Depression, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07121894: Recruiting NA study of Bipolar Depression, sponsored by Mayo Clinic.
NCT07121894 is a NA study of Bipolar Depression that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07121894, a NA study of Bipolar Depression, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.
Primary Outcome
Measured using the Quick Inventory for Depressive Symptomatology Clinician Rated (QIDS-C), a 16-item clinician rating, each rated on a four-point Likert scale (0-3). The total score ranges from 0 to 27. The QIDS-C is scored by summing the responses to the 16 items, with higher scores indicating more severe symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Ketogenic Diet
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-12 |
| Est. Completion | 2029-05-01 |
| Phase | NA |
What NCT07121894 shows while recruiting
NCT07121894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Ketogenic Diet is the first listed.
NCT07121894 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07121894 about?
NCT07121894 is a clinical study titled "Ketogenic Intervention for Bipolar Depression". The purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.
What is the current status of trial NCT07121894?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-12. Estimated completion is 2029-05-01.
What conditions does trial NCT07121894 study?
This clinical trial studies the following conditions: Bipolar Depression.
What interventions are being tested in trial NCT07121894?
The interventions under investigation include: Ketogenic Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT07121894?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07121894 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07121894's enrollment target sits among peer trials
30 20th of 29 higher than 10 of 29 other Bipolar Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
RECRUITING · NA
-
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
ACTIVE NOT RECRUITING · NA
-
Focused Ultrasound Amygdala Neuromodulation
ACTIVE NOT RECRUITING · NA
-
Biosignatures of Latuda for Bipolar Depression
COMPLETED · NA
-
Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device
COMPLETED · NA
-
Vitamin D Supplementation for Bipolar Depression
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI